MAP2K7 and lung adenocarcinoma: There is available experimental validation for both outcomes, as experiments have shown that MEK/ERK pathway activation alone did not, while a combined TGFB and MEK/ERK pathway activation did lead to a perfect EMT phenotype in a lung adenocarcinoma cell line38.